Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nimish Patel

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
LGBT Health|February 23, 2022
Method of Calculating Renal Function Estimates Could Inappropriately Exclude Transgender Patients Receiving Gender-Affirming Hormone Therapy from Pre-Exposure Prophylaxis EligibilityNimish Patel, Jill Blumenthal, Michael P Dubé, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2009
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patientsThomas P Lodise, Nimish Patel, Ben M Lomaestro, et al.
American Journal of Therapeutics|June 18, 2009
The effect of time to antifungal therapy on mortality in Candidemia associated septic shockGourang P Patel, David Simon, Marc Scheetz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 5, 2024
Predictors of Injection Visit Adherence in Those Receiving Injectable Cabotegravir/RilpivirineLucas Hill, Jeffrey Yin, Nimish Patel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2023
Predictors of Post-switch Viremia in People With HIV on Injectable Cabotegravir/RilpivirineLucas Hill, Stephanie Kenney, Nimish Patel, et al.
Annals of Hepatology|May 13, 2019
Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patientsAlisha Ahmed, Christopher Schriever, Nicholas Britt, et al.
HIV Medicine|October 13, 2025
Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapyTali Faggiano, Jeffrey Yin, Nimish Patel, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|May 3, 2024
Impact of time to treatment in first occurrence, non-severe <i>Clostridioides difficile</i> infection for elderly patients: are we waiting too long to treat?Rhett Vandervelde, Mark E Mlynarek, Mayur Ramesh, et al.
AIDS Patient Care and Stds|August 6, 2014
Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis C therapy among patients coinfected with hepatitis C and HIVNimish Patel, Michael Veve, Mona Nasiri, et al.
Infectious Diseases and Therapy|February 25, 2015
A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected PatientsNimish Patel, Mona Nasiri, Arden Koroglu, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
LGBT Health|February 23, 2022
Method of Calculating Renal Function Estimates Could Inappropriately Exclude Transgender Patients Receiving Gender-Affirming Hormone Therapy from Pre-Exposure Prophylaxis EligibilityNimish Patel, Jill Blumenthal, Michael P Dubé, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2009
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patientsThomas P Lodise, Nimish Patel, Ben M Lomaestro, et al.
American Journal of Therapeutics|June 18, 2009
The effect of time to antifungal therapy on mortality in Candidemia associated septic shockGourang P Patel, David Simon, Marc Scheetz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 5, 2024
Predictors of Injection Visit Adherence in Those Receiving Injectable Cabotegravir/RilpivirineLucas Hill, Jeffrey Yin, Nimish Patel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2023
Predictors of Post-switch Viremia in People With HIV on Injectable Cabotegravir/RilpivirineLucas Hill, Stephanie Kenney, Nimish Patel, et al.
Annals of Hepatology|May 13, 2019
Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patientsAlisha Ahmed, Christopher Schriever, Nicholas Britt, et al.
HIV Medicine|October 13, 2025
Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapyTali Faggiano, Jeffrey Yin, Nimish Patel, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|May 3, 2024
Impact of time to treatment in first occurrence, non-severe <i>Clostridioides difficile</i> infection for elderly patients: are we waiting too long to treat?Rhett Vandervelde, Mark E Mlynarek, Mayur Ramesh, et al.
AIDS Patient Care and Stds|August 6, 2014
Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis C therapy among patients coinfected with hepatitis C and HIVNimish Patel, Michael Veve, Mona Nasiri, et al.
Infectious Diseases and Therapy|February 25, 2015
A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected PatientsNimish Patel, Mona Nasiri, Arden Koroglu, et al.
Pageof 10